4
Changes in Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0001562180-20-001865
Options or other derivatives
- SVP, Chief Scientific Officer acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kaufmann Hitto · SVP, Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-27 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +45,000 | 45,000 | D |
Loading xslF345X03/primarydocument.xml…